The pharmacologic management of HTN in patients with OSA involves the use of antihypertensive medications such as Angiotensin-Converting Enzyme inhibitors (ACEi), Angiotensin II Receptor Blockers (ARBs), calcium channel blockers, and beta-blockers. This evidence concerns the gene ACE and obstructive sleep apnea syndrome.